Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The molecular events mediating the immunomodulatory properties of cannabinoids have remained largely unresolved. We have therefore investigated the molecular mechanism(s) through which R-(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl] pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-napthanlenyl) methanone (WIN55212-2) modulate production of interleukin-8 (IL-8) in HT-29 cells. Release of IL-8 induced by tumor necrosis factor-alpha (TNF-alpha) was determined by enzyme-linked immunosorbent assay (ELISA). Changes in expression of inhibitory kappa B (IkappaB) were monitored by Western blotting and activation of nuclear factor-kappa B (NF-kappaB) was determined in electrophoretic mobility shift assay (EMSAs). TNF-alpha induced release of IL-8 was inhibited by WIN55212-2 which also blocked the degradation of IkappaB-alpha and activation of NF-kappaB induced by TNF-alpha. These data provide strong evidence that WIN55212-2 may modulate IL-8 release by negatively regulating the signaling cascade leading to the activation of NF-kappaB. These findings highlight a potential mechanism for the immunomodulatory properties of cannabinoids and contribute towards acquiring a clear understanding of the role of cannabinoids in inflammation.

Original publication

DOI

10.1016/j.ejphar.2006.04.015

Type

Journal article

Journal

Eur J Pharmacol

Publication Date

01/07/2006

Volume

540

Pages

183 - 190

Keywords

Benzoxazines, Blotting, Western, Cannabinoid Receptor Agonists, Cannabinoids, Cycloheximide, Cysteine Proteinase Inhibitors, Dactinomycin, Dose-Response Relationship, Drug, Enzyme-Linked Immunosorbent Assay, HT29 Cells, Humans, I-kappa B Proteins, Interleukin-8, Leupeptins, Morpholines, NF-kappa B, Naphthalenes, Protein Synthesis Inhibitors, Receptors, Cannabinoid, Signal Transduction, Tumor Necrosis Factor-alpha, Up-Regulation